ENTITY

Immuno Cure BioTech (2163385D CH)

Analysis

Health Care • Hong Kong

Immuno Cure BioTech Limited medical technology development businesses. The Company develops gene vaccines, antibody drugs, and other products. Immuno Cure BioTech conducts businesses in China and Hong Kong.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00